EQS-Adhoc

LifeWatch AG: Dr. Christoph Heinzen nominated Chief Operations & Technology Officer

EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Change of Personnel
LifeWatch AG: Dr. Christoph Heinzen nominated Chief Operations & Technology
Officer

14.09.2016 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.

---------------------------------------------------------------------------

LifeWatch appoints Dr. Christoph Heinzen to Chief Operations & Technology
Officer

Zug/Switzerland, September 14, 2016 - LifeWatch AG (SIX Swiss Exchange:
LIFE), a leading developer and provider of medical solutions and remote
diagnostic monitoring services in the digital health market, announces that
the company's Board of Directors, on proposal by the CEO, Dr. Stephan
Rietiker, named Dr. Christoph Heinzen as Chief Operations and Technology
Officer. Dr. Heinzen, in his new role, will also serve as a member of the
Executive Management Team. Dr. Heinzen joined LifeWatch in 2015 and has,
most recently, been serving as Executive Vice President Operations and
Technology.
 
The Board of Directors congratulates Dr. Heinzen on his new position and
wishes him continued his success.


For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Dynamics Group, Doris Rudischhauser
Phone [phone] / Mobile [phone]
E-Mail: [e-mail]



About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote
diagnostic patient monitoring services. LifeWatch's services provide
physicians with critical information to determine appropriate treatment and
thereby improve patient outcomes. LifeWatch AG has operative subsidiaries
in the United States, in Switzerland and in Israel, and is the parent
company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd.
LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac
monitoring services. LifeWatch Technologies Ltd., based in Israel, is a
leading developer and manufacturer of telemedicine products. For additional
information, please visit www.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at
http://www.irlifewatch.com/websites/lifewatch_ir/English/9510/alert-
service.html

This press release includes forward-looking statements. All statements
other than statements of historical facts contained in this press release,
including statements regarding future results of operations and financial